Eikon Therapeutics Announces the Election of Kenneth C. Frazier to Its Board of Directors

HAYWARD, Calif.--(BUSINESS WIRE)-- #BOD--Former CEO of Merck, Kenneth C. Frazier, joins Eikon Therapeutics Board as an independent director.